Cargando…
Plasma ADMA associates with all-cause mortality in renal transplant recipients
Asymmetric dimethylarginine (ADMA) is a key endogenous inhibitor of endothelial NO synthase that affects endothelial function, blood pressure and vascular remodeling. Increased plasma levels of ADMA are associated with worse outcome from cardiovascular disease. Due to endothelial dysfunction before...
Autores principales: | Frenay, Anne-Roos S., van den Berg, Else, de Borst, Martin H., Beckmann, Bibiana, Tsikas, Dimitrios, Feelisch, Martin, Navis, Gerjan, Bakker, Stephan J. L., van Goor, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549386/ https://www.ncbi.nlm.nih.gov/pubmed/26077715 http://dx.doi.org/10.1007/s00726-015-2023-0 |
Ejemplares similares
-
Circulating Haptoglobin and Metabolic Syndrome in Renal Transplant Recipients
por: Minović, Isidor, et al.
Publicado: (2017) -
Physical Activity and the Development of Post-Transplant Diabetes Mellitus, and Cardiovascular- and All-Cause Mortality in Renal Transplant Recipients
por: Byambasukh, Oyuntugs, et al.
Publicado: (2020) -
Dietary Approach to Stop Hypertension (DASH) diet and risk of renal function decline and all‐cause mortality in renal transplant recipients
por: Osté, Maryse C. J., et al.
Publicado: (2018) -
Author Correction: Circulating Haptoglobin and Metabolic Syndrome in Renal Transplant Recipients
por: Minović, Isidor, et al.
Publicado: (2018) -
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018)